Theralogix is first to launch an NSF International certified CBD softgel powered by the clinically proven VESIsorb® technology FORT COLLINS, Colo., April 11, 2022 (GLOBE NEWSWIRE) -- Geocann and Theralogix are proud to announce the successful launch of a cannabidiol (CBD) and beta-caryophyllene (BCP) softgel formulation...

Nestlé Health Science expands distribution of hemp products formulated with VESIsorb® into Europe under industry-leading brand, Pure Encapsulations® FORT COLLINS, Colo., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Geocann and Nestlé Health Science are proud to announce the European launch of CBD (from broad spectrum hemp extract) soft gel formulations...

Geocann and Sunderstorm enter agreement to expand California leadership position across the U.S. with VESIsorb® formulated cannabis products FORT COLLINS, Colo., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce a strategic partnership with Sunderstorm that will bring VESIsorb® formulated cannabis products to millions of...

Geocann introduces the industry’s first 4-in-1 immunity support formulation utilizing the patented VESIsorb® drug delivery system FORT COLLINS, Colo., July 30, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has commercialized the first oral dose application that overcomes the well-known bioavailability...

Geocann’s VESIsorb® cannabidiol formulation delivers superior pharmacokinetic performance in published study FORT COLLINS, Colo., April 14, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the peer-reviewed journal, Molecules, has published the results of a double-blind, cross-over study...